Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
20.48
-0.05 (-0.24%)
Feb 13, 2026, 3:04 PM CST
SHE:300653 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 67.49 | 116.84 | 76.58 | 82.49 | 126.49 | 193.26 |
Trading Asset Securities | 544.95 | 505.43 | 598.61 | 534.21 | 445.18 | 251.55 |
Cash & Short-Term Investments | 612.43 | 622.27 | 675.19 | 616.7 | 571.67 | 444.81 |
Cash Growth | 0.43% | -7.84% | 9.48% | 7.88% | 28.52% | -1.85% |
Accounts Receivable | 57.82 | 50.77 | 53.6 | 46.85 | 46.8 | 54.56 |
Other Receivables | 2.97 | 0.64 | 1.16 | 1.49 | 0.74 | 0.87 |
Receivables | 60.79 | 51.41 | 54.76 | 48.34 | 47.54 | 55.42 |
Inventory | 29.66 | 35.18 | 36.72 | 40.69 | 33.98 | 23.64 |
Other Current Assets | 9.29 | 3.84 | 3.97 | 4.27 | 10.2 | 3.2 |
Total Current Assets | 712.18 | 712.7 | 770.63 | 710.01 | 663.38 | 527.08 |
Property, Plant & Equipment | 217.43 | 230.09 | 243.43 | 228.03 | 219.79 | 234.04 |
Other Intangible Assets | 30.56 | 32.53 | 35.01 | 37.22 | 38.11 | 40.72 |
Long-Term Deferred Tax Assets | 1.88 | 2.33 | 2.78 | 2.67 | 2.24 | 2.73 |
Long-Term Deferred Charges | - | 0.02 | 0.26 | 0.69 | 0.87 | - |
Other Long-Term Assets | 2.8 | 2.45 | 1.71 | 8.29 | 4.53 | 0.96 |
Total Assets | 964.85 | 980.11 | 1,054 | 986.9 | 928.92 | 805.54 |
Accounts Payable | 12.07 | 21.82 | 39.11 | 58.88 | 70.01 | 92.27 |
Accrued Expenses | 17.02 | 12.27 | 15.9 | 21.92 | 23 | 11.59 |
Current Income Taxes Payable | 6.49 | 1.25 | 6.4 | 6.66 | - | 0.99 |
Current Unearned Revenue | 8.08 | 13.94 | 12.85 | 6.17 | 22.07 | 28.96 |
Other Current Liabilities | 36.44 | 31.51 | 15.75 | 11.98 | 10.96 | 11.14 |
Total Current Liabilities | 80.1 | 80.79 | 90 | 105.61 | 126.03 | 144.95 |
Long-Term Unearned Revenue | 4.69 | 4.87 | 9.12 | 9.96 | 10.48 | 13.87 |
Long-Term Deferred Tax Liabilities | 5.59 | 5.67 | 6.63 | 6.22 | 7.14 | - |
Total Liabilities | 90.38 | 91.33 | 105.76 | 121.8 | 143.65 | 158.82 |
Common Stock | 180 | 180 | 180 | 180 | 120 | 120 |
Additional Paid-In Capital | 169.42 | 169.42 | 169.42 | 169.42 | 229.42 | 229.42 |
Retained Earnings | 574.97 | 589.29 | 598.65 | 515.69 | 435.85 | 297.3 |
Treasury Stock | -49.92 | -49.92 | - | - | - | - |
Shareholders' Equity | 874.47 | 888.78 | 948.07 | 865.11 | 785.27 | 646.72 |
Total Liabilities & Equity | 964.85 | 980.11 | 1,054 | 986.9 | 928.92 | 805.54 |
Net Cash (Debt) | 612.43 | 622.27 | 675.19 | 616.7 | 571.67 | 444.81 |
Net Cash Growth | 0.43% | -7.84% | 9.48% | 7.88% | 28.52% | -1.85% |
Net Cash Per Share | 3.40 | 3.47 | 3.75 | 4.26 | 3.19 | 2.48 |
Filing Date Shares Outstanding | 177.64 | 177.64 | 180 | 180 | 180 | 180 |
Total Common Shares Outstanding | 177.64 | 177.64 | 180 | 180 | 180 | 180 |
Working Capital | 632.08 | 631.91 | 680.63 | 604.39 | 537.35 | 382.13 |
Book Value Per Share | 4.92 | 5.00 | 5.27 | 4.81 | 4.36 | 3.59 |
Tangible Book Value | 843.91 | 856.25 | 913.05 | 827.89 | 747.16 | 605.99 |
Tangible Book Value Per Share | 4.75 | 4.82 | 5.07 | 4.60 | 4.15 | 3.37 |
Buildings | - | 194.22 | 192.63 | 161.32 | 156.76 | 65.92 |
Machinery | - | 136.66 | 125.6 | 117.8 | 109.13 | 37.92 |
Construction In Progress | - | 1.34 | 8.09 | 14.63 | 4.35 | 166.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.